{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:32:21Z","timestamp":1758126741397,"version":"3.44.0"},"reference-count":43,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2021,6,15]]},"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1136\/ejhpharm-2021-002739","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T13:28:43Z","timestamp":1624886923000},"page":"208-213","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of angiotensin II receptor blockers on serum potassium level and hyperkalemia risk: retrospective single-centre analysis"],"prefix":"10.1136","volume":"30","author":[{"given":"Sakae","family":"Fukushima","sequence":"first","affiliation":[{"name":"Pharmacy, Nihon University Itabashi Hospital, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manami","family":"Oishi","sequence":"additional","affiliation":[{"name":"Nihon University School of Pharmacy, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Aso","sequence":"additional","affiliation":[{"name":"Nihon University School of Pharmacy, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kifumi","family":"Arai","sequence":"additional","affiliation":[{"name":"Pharmacy, Nihon University Hospital, Chiyoda-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Pharmacy, Nihon University Hospital, Chiyoda-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Tochikura","sequence":"additional","affiliation":[{"name":"Pharmacy, Nihon University Itabashi Hospital, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Ootsuka","sequence":"additional","affiliation":[{"name":"Pharmacy, Nihon University Itabashi Hospital, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyasu","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Nihon University School of Pharmacy, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Ooba","sequence":"additional","affiliation":[{"name":"Nihon University School of Pharmacy, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Pharmacy, Nihon University Hospital, Chiyoda-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"2025090702553772000_30.4.208.1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/5584_2016_99","article-title":"Hypertension is a risk factor for several types of heart disease: review of prospective studies","volume":"956","author":"Kokubo","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"2025090702553772000_30.4.208.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-019-0284-9"},{"key":"2025090702553772000_30.4.208.3","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000066"},{"key":"2025090702553772000_30.4.208.4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"2025090702553772000_30.4.208.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.4.466"},{"key":"2025090702553772000_30.4.208.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2009.01.002"},{"key":"2025090702553772000_30.4.208.7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/ggi.13276","article-title":"Current use of antihypertensive drugs in Japanese patients with hypertension: analysis by age group","volume":"18","author":"Ishida","year":"2018","journal-title":"Geriatr Gerontol Int"},{"key":"2025090702553772000_30.4.208.8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/HYPERTENSIONAHA.116.08128","article-title":"Trends in antihypertensive medication use among US patients with resistant hypertension, 2008 to 2014","volume":"68","author":"Hwang","year":"2016","journal-title":"Hypertension"},{"key":"2025090702553772000_30.4.208.9","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.amjcard.2017.08.042","article-title":"Seventeen-Year nationwide trends in antihypertensive drug use in Denmark","volume":"120","author":"Sundb\u00f8ll","year":"2017","journal-title":"Am J Cardiol"},{"key":"2025090702553772000_30.4.208.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2009.01047.x"},{"key":"2025090702553772000_30.4.208.11","article-title":"Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany","author":"Rudolph","year":"2020","journal-title":"J Hum Hypertens"},{"key":"2025090702553772000_30.4.208.12","first-page":"410","article-title":"Pattern analysis and variations in the utilization of antihypertensive drugs in Taiwan: a six-year study","volume":"17","author":"Huang","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025090702553772000_30.4.208.13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-1-200801010-00190"},{"key":"2025090702553772000_30.4.208.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"2025090702553772000_30.4.208.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011303"},{"key":"2025090702553772000_30.4.208.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011489"},{"key":"2025090702553772000_30.4.208.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2015.11.005"},{"key":"2025090702553772000_30.4.208.18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/hr.2015.82","article-title":"Impact of irbesartan, an angiotensin receptor blocker, on uric acid level and oxidative stress in high-risk hypertension patients","volume":"38","author":"Chida","year":"2015","journal-title":"Hypertens Res"},{"key":"2025090702553772000_30.4.208.19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001941"},{"key":"2025090702553772000_30.4.208.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80099-0"},{"key":"2025090702553772000_30.4.208.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2005.08.005"},{"key":"2025090702553772000_30.4.208.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.02.034"},{"key":"2025090702553772000_30.4.208.23","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12109"},{"key":"2025090702553772000_30.4.208.24","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1217"},{"key":"2025090702553772000_30.4.208.25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/phar.2051","article-title":"Incidence of and risk factors for severe adverse events in elderly patients taking angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers after an acute myocardial infarction","volume":"38","author":"Fang","year":"2018","journal-title":"Pharmacotherapy"},{"key":"2025090702553772000_30.4.208.26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005428"},{"key":"2025090702553772000_30.4.208.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62459-4"},{"key":"2025090702553772000_30.4.208.28","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfk058"},{"key":"2025090702553772000_30.4.208.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14285-7"},{"key":"2025090702553772000_30.4.208.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001121"},{"key":"2025090702553772000_30.4.208.31","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328351856d"},{"key":"2025090702553772000_30.4.208.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805450"},{"key":"2025090702553772000_30.4.208.33","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg231"},{"key":"2025090702553772000_30.4.208.34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7497.960"},{"key":"2025090702553772000_30.4.208.35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MEJ.0000000000000691","article-title":"Acute hyperkalemia in the emergency department: a summary from a kidney disease: improving global outcomes conference","volume":"27","author":"Lindner","year":"2020","journal-title":"Eur J Emerg Med"},{"key":"2025090702553772000_30.4.208.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2010.00258.x"},{"key":"2025090702553772000_30.4.208.37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000479011","article-title":"Impact of renin-angiotensin aldosterone system inhibition on serum potassium levels among peritoneal dialysis patients","volume":"46","author":"Ribeiro","year":"2017","journal-title":"Am J Nephrol"},{"key":"2025090702553772000_30.4.208.38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/HJH.0000000000000478","article-title":"Losartan treatment for hypertensive patients with hyperuricaemia in Chinese population: a meta-analysis","volume":"33","author":"Fan","year":"2015","journal-title":"J Hypertens"},{"key":"2025090702553772000_30.4.208.39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1291\/hypres.31.295","article-title":"Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: the Japan hypertension evaluation with angiotensin II antagonist losartan therapy (J-HEALTH) study","volume":"31","author":"Naritomi","year":"2008","journal-title":"Hypertens Res"},{"key":"2025090702553772000_30.4.208.40","doi-asserted-by":"publisher","DOI":"10.1177\/2040622315596119"},{"key":"2025090702553772000_30.4.208.41","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2008.245"},{"key":"2025090702553772000_30.4.208.42","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1922-6"},{"key":"2025090702553772000_30.4.208.43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000052400","article-title":"Treatment satisfaction of patients with lower urinary tract symptoms: randomised controlled trials vs. real life practice","volume":"38 Suppl 1","author":"Michel","year":"2000","journal-title":"Eur Urol"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2021-002739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:55:46Z","timestamp":1757238946000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2021-002739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,6,22]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/ejhpharm-2021-002739"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2021-002739","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2021,6,28]]}}}